Dr. Rob Grundy, CEO of Anglezarke
Dr Robert Grundy is the founder of Anglezarke Life Sciences. He was previously CEO of CIGA Healthcare Ltd and Director of Commercial Development and Licensing at Almac Discovery. Rob’s focus is on the commercial development of differentiating innovation across science and technology. Rob also holds the position of Honorary Lecturer in the School of Medicine Dentistry and Biomedical Sciences at Queen’s University Belfast
As a member of the Aerospace Growth Partnership leadership team, Gavin has been an active technology leader in one of the UKs foremost industrial sectors. He is a non-executive director of the Aerospace Technology Institute and of the NI Advanced Engineering Competence Centre. He is committed to innovation-led engineering excellence and believes that investing in people and technology is key to economic development.
Gavin is a visiting Professor in the Faculty of Computing and Engineering at the University of Ulster, a Fellow of the Institution of Mechanical Engineers and a Fellow of the Irish Academy of Engineering. He is also a STEM Ambassador.
Colette studied Psychology at Queen’s University Belfast where she gained her BA in 1981, and continued then to study nursing to gain her RGN in 1984. In 1988 she joined Upjohn Limited as a Clinical Research Associate and in 1994 she completed her MSc at QUB. She continued her career in Clinical Research remaining with Upjohn as it transitioned to Pharmacia in 1996 and then Pfizer in 2003.
Her current remit is to encourage growth and investment in Northern Ireland from lead pharmaceutical companies and Global Contract Research Organizations by the placement of clinical trials in the primary and secondary care sectors.
In recent years Professor McLaughlin’s over-arching strategy is to develop a strong Connected Health Platform within Northern Ireland. This involves enhancing the links between bioengineering and computing sciences with sensor systems technology developed within NIBEC and thus facilitating clinically-led research initiatives to benefit the healthcare sector.
A holder of over twenty patents, he has successfully co-founded a set of award winning spin-out companies including the highly successful connected health company – Intelesens Ltd. He is currently the Chief Technology Officer with Intelesens and is a director with SISAF and NORIBIC. Professor McLaughlin has held positions on committees such: RAE 2008 Materials Assessment Panel; Chair of the MATRIX Advanced Materials Panel; EPSRC College; NanoIreland Task Force/Chaired the Nanomaterials Panel; Advisory panel to MSSI and Chair of European Connected Health Campus.
He was recently awarded an OBE for his services to Research and Economic Development in Northern Ireland.